Cite

HARVARD Citation

    Choi, K. et al. (2019). Repeated low-dose rituximab treatment based on the assessment of circulating B cells in patients with refractory myasthenia gravis. Therapeutic advances in neurological disorders. p. . [Online]. 
  
Back to record